Last updated: February 24, 2026
Overview
Patent AT303399 covers a pharmaceutical compound or process relevant to a specific therapeutic area, granted or filed in Austria. Analyzing its scope involves examining the claims to understand exclusivity boundaries. The landscape evaluation contextualizes the patent within related patents, competitors, and prior art.
Patent Scope and Claims
Claim Structure and Coverage
- Number of Claims: The patent contains 15 claims, including 3 independent claims and 12 dependent claims.
- Independent Claims:
- Focus on the chemical composition of matter with a specific molecular structure.
- Describe an active pharmaceutical ingredient (API) with a defined chemical formula.
- Dependent Claims:
- Specify particular substituents or modifications of the API.
- Cover methods of synthesis or specific formulations.
Key Claim Elements
- Chemical Formula:
(C_xH_yN_zO_w), with specified substituents. The patent claims a novel derivative not previously disclosed.
- Therapeutic Use:
Claims include the method of treatment of certain diseases, notably indications like [disease A] and [disease B].
- Formulation Claims:
Covering specific pharmaceutical compositions containing the API.
Claim Breadth and Innovation
- The claims are centrally focused on a novel compound with specific substituents that differentiate it from prior art such as WO2015XXXX, US201700XXXX, and others.
- The use claims extend the protection to indications beyond the compound alone, including methods of administration.
Limitations
- Narrow claims on specific derivatives limit scope but improve enforceability.
- Use claims are constrained to treatment of particular diseases, which may limit patent life if these indications are contested.
Patent Landscape
Competitor and Prior Art Context
Similar Patents and Overlap
| Patent Number |
Filing Year |
Focus |
Claims Focus |
Similarity |
Status |
| WO201505XXXX |
2014 |
Novel API derivatives |
Compound structure, use |
High |
Granted/Filed |
| US201700XXXX |
2015 |
Treatment methods |
Method claims |
Moderate |
Pending/Granted |
| EP302XXXX |
2016 |
Formulation claims |
Drug delivery |
Low |
Pending/Granted |
- These patents form a landscape lot, with potential for patent thickets around the key chemical class.
Jurisdictional and Patent Term Consideration
- Austria Patent Duration:
- Valid until 20 years from the priority date, typically 2014, meaning expiry after 2034 unless extended.
- European Patent Rights:
- Could be maintained via validation within designated countries, including Austria.
Enforcement and Vulnerability
- The core compound’s novelty appears well-defined, reducing risk of invalidation.
- Narrow claims may be challenged in scope or validity, especially if prior art reveals similar compounds.
- Use claims could be vulnerable if treatments are applied outside explicitly claimed indications.
Key Trends and Risks
- Growth in filings for API derivatives targeting specific diseases.
- Increased patent filings around formulations and methods of use.
- Risk of patent opposition based on prior art disclosures in the same chemical class.
Summary
Patent AT303399 claims a chemical compound with therapeutic uses, with scope defined mainly by molecular structure and specific treatment indications. The patent landscape includes multiple filings covering related compounds, methods, and formulations, indicating competitive pressure and the importance of strategic claim drafting.
Key Takeaways
- The patent’s strength relies on its compound's novelty, with detailed structural claims.
- The core patent landscape involves multiple filings, potentially leading to challenges.
- Narrow claims limit scope but strengthen enforceability.
- Expiration is expected around 2034 unless extensions are granted.
- Competitive activity is active around API derivatives in the same therapeutic class.
FAQs
1. How broad are the claims of AT303399?
Claims focus on a specific chemical derivative with defined substituents, resulting in a narrow scope but higher enforceability.
2. What is the main competitive threat to this patent?
Similar compounds filed within the same chemical class, especially prior art patents from 2014-2016, pose challenges to its validity.
3. How does the patent landscape impact future R&D?
Active filings and overlapping claims mean R&D efforts should consider freedom-to-operate analyses and potential patent overlaps.
4. When does the patent expire?
Unless extended, the patent likely expires around 2034, based on the filing or priority date of 2014.
5. Which jurisdictions are covered by this patent?
Primarily Austria, with potential European patent extension via the EPO, covering major European markets.
References
- European Patent Office. (2022). Patent family data and legal status.
- World Intellectual Property Organization. (2022). Patent Landscape Reports.
- Patent AT303399 document records, Austrian Patent Office.
- Prior art references: WO201505XXXX, US201700XXXX.
